{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:15:03Z","timestamp":1792088103880,"version":"4.4.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jaci.2006.07.024","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:22:19Z","timestamp":1157181739000},"page":"773-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":253,"title":["Clinical and pathologic perspectives on aspirin sensitivity and asthma"],"prefix":"10.1016","volume":"118","author":[{"given":"Donald D.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2006.07.024_bib1","first-page":"189","article-title":"Anaphylaxie et idiosyncrasie","volume":"30","author":"Widal","year":"1922","journal-title":"Presse Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0021-8707(67)90076-7","article-title":"Concerning the nature of the intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin: clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mai.2002.123024","article-title":"Sinusitis and asthma: entering the realm of evidence-based medicine","volume":"109","author":"Borish","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, Oct 2003","volume":"113","author":"Johannessen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin-induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2006.07.024_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/28.4.717","article-title":"Prevalence of asthma,\u00a0aspirin intolerance, nasal polyps and chronic obstructive pulmonary disease in a population-based study","volume":"28","author":"Hedman","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaci.2006.07.024_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1034\/j.1398-9995.2003.00267.x","article-title":"Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland","volume":"58","author":"Kasper","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2006.07.024_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2222.1976.tb01896.x","article-title":"The diagnosis of aspirin idiosyncrasy by analgesic challenge","volume":"6","author":"Delaney","year":"1976","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0091-6749(72)90014-0","article-title":"Aspirin intolerance in asthma\u2014detection by challenge","volume":"50","author":"McDonald","year":"1972","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(79)90059-9","article-title":"Aspirin and concomitant idiosyncrasies in adult asthmatic patients","volume":"64","author":"Spector","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.1975.00330060021002","article-title":"A study of provoking factors in bronchial asthma","volume":"135","author":"Stevenson","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0091-6749(79)90080-0","article-title":"Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics","volume":"64","author":"Weber","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.56.3.443","article-title":"Aspirin intolerance in chronic childhood asthma: detection by oral challenge","volume":"56","author":"Rachelefsky","year":"1975","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2006.07.024_bib17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0091-6749(83)90439-6","article-title":"Aspirin-sensitive rhinosinusitis\/asthma: spectrum of adverse reactions to aspirin","volume":"71","author":"Pleskow","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2222.1988.tb02838.x","article-title":"Aspirin-induced asthma as a viral disease","volume":"18","author":"Szczeklik","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0091-6749(99)70011-4","article-title":"Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in mice","volume":"104","author":"Diaz-Sanchez","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib22","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.172.6.3808","article-title":"Diesel exhaust particles suppress in vivo IFN-gamma production by inhibiting cytokine effects on NK and NKT cells","volume":"172","author":"Finkelman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0300-483X(00)00418-2","article-title":"Effect of diesel exhaust particles and their components on the allergen-specific IgE and IgG1 response in mice","volume":"159","author":"Heo","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.jaci.2006.07.024_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1021\/cr50029a004","article-title":"The chemical constituents of tobacco and tobacco smoke","volume":"59","author":"Johnstone","year":"1959","journal-title":"Chem Rev"},{"key":"10.1016\/j.jaci.2006.07.024_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1398-9995.1994.tb02100.x","article-title":"Indoor factors and serum IgE levels in children","volume":"49","author":"Wjst","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib26","series-title":"Allergy: principles and practice","first-page":"1695","article-title":"Sensitivity to aspirin and NSAIDs","author":"Stevenson","year":"2003"},{"key":"10.1016\/j.jaci.2006.07.024_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","article-title":"Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis","volume":"60","author":"Szczeklik","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-66-3-568","article-title":"Bronchial asthma induced by indomethacin","volume":"66","author":"Vanselow","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","article-title":"Relationship of inhibition\u00a0of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients","volume":"1","author":"Szczeklik","year":"1975","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2006.07.024_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0091-6749(79)90036-8","article-title":"Hypersensitivity to non-steroidal anti-inflammatory drugs: indications and methods for oral challenge","volume":"64","author":"Mathison","year":"1979","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/CRIAI:24:2:149","article-title":"Cross-reacting drugs and chemicals","volume":"24","author":"Woessner","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0091-6749(89)90174-7","article-title":"Cross sensitivity with acetaminophen in aspirin sensitive asthmatics","volume":"84","author":"Settipane","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib33","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(05)80179-4","article-title":"Disalcid cross-sensitivity in aspirin sensitive asthmatics","volume":"86","author":"Stevenson","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib34","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2000.00698.x","article-title":"Multiple sensitivities to NSAIDs","volume":"55","author":"Asero","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1081-1206(10)62412-X","article-title":"Tolerability of meloxicam in patients with histories of adverse\u00a0reactions to nonsteroidal anti-inflammatory drugs","volume":"84","author":"Quaratino","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib36","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3109\/02770909909055417","article-title":"The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance","volume":"36","author":"Bavbek","year":"1999","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2006.07.024_bib37","first-page":"715","article-title":"Tolerance of meloxicam in aspirin-sensitive asthmatics","volume":"157","author":"Vaghi","year":"1998","journal-title":"Am J\u00a0Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1081\/JAS-120026063","article-title":"Safety of selective COX-2 inhibitors in aspirin\/NSAID intolerant patients: comparison of nimesulide, meloxicam and rofecoxib","volume":"41","author":"Bavbek","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2006.07.024_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mai.2001.116290","article-title":"Lack of cross-reactivity between rofecoxib and aspirin in aspirin sensitive asthmatic patients","volume":"108","author":"Stevenson","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib40","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1378\/chest.121.6.1812","article-title":"Safety of a cyclooxygenase-2 inhibitor in patients with aspirin- sensitive asthma(\u2217)","volume":"121","author":"Martin-Garcia","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2006.07.024_bib41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2222.2001.01075.x","article-title":"Safety of a specific COX-2 inhibitor in aspirin-induced asthma","volume":"31","author":"Szczeklik","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib42","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1067\/mai.2000.110926","article-title":"Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma","volume":"106","author":"Yoshida","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib43","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/art.10426","article-title":"The safety of celecoxib in aspirin exacerbated respiratory disease","volume":"46","author":"Woessner","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2006.07.024_bib44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1067\/mai.2003.1450","article-title":"Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib","volume":"111","author":"Gyllfors","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2006.02.011","article-title":"Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"117","author":"Vola","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003088-200544120-00004","article-title":"Clinical and pharmacology of lumiracoxib: a selective cyclo-oxygenase-2 inhibitor","volume":"44","author":"Rordorf","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaci.2006.07.024_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2005.10.021","article-title":"Asthma attacks induced by low doses of celecoxib, aspirin and acetaminophen","volume":"117","author":"Baldassarre","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1081-1206(10)61392-0","article-title":"Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease","volume":"93","author":"Woessner","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2006.06.028","article-title":"Different eicosanaoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis and asthma","volume":"118","author":"Mastalerz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib50","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1378\/chest.123.6.2155","article-title":"Cyclo-oxygenase-2 inhibitors in aspirin sensitive asthma","volume":"123","author":"Passero","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2006.07.024_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1398-9995.2005.00878.x","article-title":"Multiple drug intolerance, including etoricoxib","volume":"61","author":"Morias-Almeida Marinho","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawley","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2006.07.024_bib53","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroidal drug selectivity for cyco-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2006.07.024_bib54","first-page":"745","article-title":"Anaphylactic and anaphylactoid reactions to aspirin and nonsteroidal anti-inflammatory drugs","volume":"21","author":"Stevenson","year":"2001","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2006.07.024_bib55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1081-1206(10)62327-7","article-title":"Anaphylaxis to celecoxib","volume":"87","author":"Levy","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000051790","article-title":"Fixed drug eruption to rofecoxib with cross-reactivity to sulfonamides","volume":"203","author":"Kaur","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2006.07.024_bib57","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.20424","article-title":"The discovery and development of anti-inflammatory drugs","volume":"50","author":"Brune","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2006.07.024_bib58","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1365-2222.2004.02050.x","article-title":"The flow-cytometric determination of basophil activation by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome","volume":"34","author":"Gamboa","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2500\/108854188778995020","article-title":"Oral challenges to detect aspirin and sulfite sensitivity\u00a0in asthma","volume":"9","author":"Stevenson","year":"1988","journal-title":"New England Regional Allergy Proceedings"},{"key":"10.1016\/j.jaci.2006.07.024_bib60","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.93.03050527","article-title":"Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics","volume":"3","author":"Dahlen","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib61","first-page":"61","article-title":"Dosimeter inhalation test with lysine acetylsalicylate for the detection of aspirin-induced asthma","volume":"71","author":"Melillo","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","article-title":"Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma","volume":"15","author":"Nizankowska","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib63","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1034\/j.1398-9995.2002.t01-1-13447.x","article-title":"Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma","volume":"57","author":"Alonso-Llamazares","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2006.03.017","article-title":"Changes in urinary LTE4 and nasal function following nasal provocation tests with ASA-tolerant and -intolerant asthmatics","author":"Micheletto","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","article-title":"Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma","volume":"101","author":"Milewski","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib66","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1398-9995.2001.00913.x","article-title":"Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma","volume":"56","author":"Mita","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.34.5.654","article-title":"Inhibition of idiosyncratic reactions to aspirin\u00a0in asthmatic patients by clemastine","volume":"34","author":"Szczeklik","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2006.07.024_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2500\/108854184779063748","article-title":"Oral challenge, aspirin, NSAID, tartrazine, and sulfites","volume":"5","author":"Stevenson","year":"1984","journal-title":"N Engl Regional Allergy Proc"},{"key":"10.1016\/j.jaci.2006.07.024_bib69","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","article-title":"The effect of leukotriene modifier drugs on asa-induced asthma and rhinitis reactions","volume":"32","author":"Berges-Gimeno","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib71","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1034\/j.1398-9995.2001.00025.x","article-title":"Report of the INTERASMA Working Group on Standardization of Inhalation\u00a0Provocation Tests in Aspirin-induced Asthma. Oral and inhalation\u00a0provocation tests for the diagnosis of aspirin-induced asthma","volume":"56","author":"Melillo","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1398-9995.1991.tb04218.x","article-title":"Inhalation and nasal challenge in the diagnosis of aspirin induced asthma","volume":"46","author":"Pawlowicz","year":"1991","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib73","doi-asserted-by":"crossref","unstructured":"White AA, Stevenson DD. Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2006 In press.","DOI":"10.1016\/S1081-1206(10)60012-9"},{"key":"10.1016\/j.jaci.2006.07.024_bib74","first-page":"15","article-title":"Etiology of\u00a0nasal polyps associated with aspirin-sensitive asthma","volume":"8","author":"Yamashita","year":"1989","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2006.07.024_bib75","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib76","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated\u00a0in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1398-9995.1998.tb03767.x","article-title":"The role of cytokines in infectious sinusitis and nasal polyposis","volume":"53","author":"Bachert","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus non-allergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib79","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.156.5.9702072","article-title":"Expression\u00a0of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatic\u00a0airways","volume":"156","author":"Sousa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib80","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/eji.1830260837","article-title":"Human eotaxin represents a potent activator of the respiratory burst in human eosinophils","volume":"26","author":"Elsner","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib81","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","article-title":"Cysteinyl leukotrienes and their receptors: cellular\u00a0distribution and function in immune and inflammatory responses","volume":"173","author":"Kanaoka","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib82","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1084\/jem.20042407","article-title":"Leukotriene B4, activation product of mast cells, is a chemoattractant for their progenitors","volume":"201","author":"Weller","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib83","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Over expression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2006.07.024_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1067\/mhn.2002.121913","article-title":"Aspirin-sensitive versus non-aspirin-sensitive nasal polyp patients: analysis of leukotrienes\/Fas and Fas-ligand expression","volume":"126","author":"Ziroli","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2006.07.024_bib85","first-page":"130","article-title":"Nasal polyposis\u2014a new concept on the formation of polyps","volume":"11","author":"Bachert","year":"1999","journal-title":"ACI Int"},{"key":"10.1016\/j.jaci.2006.07.024_bib86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib87","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib88","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2006.07.024_bib89","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","article-title":"Urinary leukotriene E4 in bronchial asthma","volume":"5","author":"Smith","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib90","first-page":"290","article-title":"Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma","volume":"23","author":"Sanak","year":"2000","journal-title":"Am\u00a0J\u00a0Respir\u00a0Cell Mol Biol"},{"key":"10.1016\/j.jaci.2006.07.024_bib91","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0140-6736(05)64015-9","article-title":"Leukotriene C4 synthase promotor polymorphism and risk of aspirin-induced asthma","volume":"350","author":"Sanak","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2006.07.024_bib92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1067\/mai.2000.107603","article-title":"5\u2032 flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States","volume":"106","author":"Van Sambeek","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib93","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mai.2001.112853","article-title":"Leukotriene C4 synthase polymorphism and aspirin-induced asthma","volume":"107","author":"Sanak","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib94","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib95","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.plipres.2005.04.002","article-title":"Biochemistry, biology, chemistry of the 5-lipoxygenase product 5-oxo-ETE","volume":"44","author":"Powell","year":"2005","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jaci.2006.07.024_bib96","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3003.2000.16a08.x","article-title":"Aspirin-tolerant asthmatics generate more lipoxins than aspirin- intolerant asthmatics","volume":"16","author":"Sanak","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib97","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1046\/j.1365-2222.2002.01529.x","article-title":"Products of 15-LO: Are they important in asthma?","volume":"32","author":"Nasser","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib98","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm748","article-title":"Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4","volume":"8","author":"Levy","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib99","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene and lipoxin balance in chronic rhinosinusitis with and without nasal polyps","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-6749(03)01716-0","article-title":"Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generated by leukocytes from aspirin sensitive asthmatic patients","volume":"112","author":"Kowalski","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha11beta-PGF2 (a PGD2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenges","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib102","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.102.042937","article-title":"15R-methyl-prostaglandin D2 is a potent and selective CRTH\/DP2 receptor agonist in human eosinophils","volume":"304","author":"Monneret","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2006.07.024_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0952-3278(03)00079-6","article-title":"A novel PGD2 receptor expressed in eosinophils","volume":"69","author":"Powell","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jaci.2006.07.024_bib104","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)90799-8","article-title":"Prostaglandin E2 and aspirin-induced asthma","volume":"345","author":"Szczeklik","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2006.07.024_bib105","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1183\/09031936.99.13363899","article-title":"Dynamics of eicosanoids in peripheral\u00a0blood cells during bronchial provocation in aspirin-intolerant asthmatics","volume":"13","author":"Schaefer","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2006.07.024_bib106","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/hmg\/ddh332","article-title":"Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach","volume":"15","author":"Jinnai","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2006.07.024_bib107","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2005.10.037","article-title":"Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression","volume":"117","author":"Ying","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib108","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni1188","article-title":"Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3","volume":"6","author":"Kunikata","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib109","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2005.12.053","article-title":"The broken balance in aspirin hypersensitivity","volume":"533","author":"Szczeklik","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaci.2006.07.024_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00439-004-1082-1","article-title":"Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyper responsiveness","volume":"114","author":"Choi","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2006.07.024_bib111","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaci.2003.12.012","article-title":"HLA association in aspirin intolerant asthma: DPB1\u22170301 as a strong marker in a\u00a0Korean population","volume":"113","author":"Choi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib112","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2222.1997.tb00747.x","article-title":"Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes","volume":"27","author":"Dekker","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib113","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2222.2005.02188.x","article-title":"Polymorphisms in the 5-lipoxygenase activating protein (ALOX5AP) gene are not associated with asthma in an Australian population","volume":"35","author":"Kedda","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib114","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1398-9995.2005.00780.x","article-title":"Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness","volume":"60","author":"Kim","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib115","first-page":"113","article-title":"Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs","volume":"59","author":"Szczeklik","year":"1987","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","article-title":"Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2\u00a0in\u00a0response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics","volume":"146","author":"Kumlin","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2006.07.024_bib117","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1164\/ajrccm\/137.4.847","article-title":"Release of\u00a0leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin","volume":"137","author":"Ferreri","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2006.07.024_bib118","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0091-6749(94)90123-6","article-title":"Direct evidence for a role of the mast cell in the nasal response to aspirin\u00a0in\u00a0aspirin-sensitive asthma","volume":"94","author":"Fischer","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib119","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0091-6749(93)90264-G","article-title":"Nasal secretions in response to acetylsalicylic acid","volume":"91","author":"Kowalski","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib121","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib122","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1164\/ajrccm.153.2.8564099","article-title":"Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma","volume":"153","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","article-title":"Cyclooxygenase-2 mRNA is down expressed in nasal polyps from aspirin-sensitive asthmatics","volume":"160","author":"Picado","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib124","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2004.07.050","article-title":"Dynamics\u00a0of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma","volume":"114","author":"Pujols","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2006.07.024_bib126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1365-2222.1996.tb00612.x","article-title":"Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients","volume":"26","author":"Kowalski","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib127","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0091-6749(91)90238-J","article-title":"Tryptase and histamine release during aspirin-induced respiratory reactions","volume":"88","author":"Bosso","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0091-6749(95)70002-1","article-title":"Inhibition of monocyte leukotriene B4 production following aspirin desensitization","volume":"96","author":"Juergens","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1398-9995.1997.tb01248.x","article-title":"Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients\u00a0with aspirin-induced asthma","volume":"52","author":"Mastalerz","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.07.024_bib130","first-page":"340","article-title":"Aspirin sensitivity in rhinosinusitis and asthma","volume":"5","author":"Mathison","year":"1983","journal-title":"Immunol Allergy Pract"},{"key":"10.1016\/j.jaci.2006.07.024_bib131","first-page":"376","article-title":"The Swedish-Polish treatment study with the 5-lipoxygenase inhibitor Zileuton in aspirin-intolerant asthmatics","volume":"151","author":"Dahlen","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib132","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton\u00a0to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","article-title":"Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: A randomized, double blind, placebo controlled trial","volume":"165","author":"Dahlen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.07.024_bib134","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2362.2002.01088.x","article-title":"Clinical and genetic features underlying the response of patients with bronchial asthma to treatment with a leukotriene receptor antagonist","volume":"32","author":"Mastalerz","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2006.07.024_bib135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1046\/j.1365-2745.2002.01484.x","article-title":"Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma","volume":"32","author":"Mastalerz","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"suppl","key":"10.1016\/j.jaci.2006.07.024_bib136","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1136\/thorax.55.suppl_2.S28","article-title":"Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast","volume":"55","author":"Sampson","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2006.07.024_bib137","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00008571-200210000-00009","article-title":"Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to an LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma","volume":"12","author":"Asano","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jaci.2006.07.024_bib138","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jaci.2004.05.051","article-title":"The HLA-DPB1\u22170301 marker might predict the requirement for leukotriene receptor\u00a0antagonist in patients with aspirin-intolerant asthma","volume":"114","author":"Park","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib139","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2500\/105065897781446702","article-title":"Surgical treatment of aspirin triad sinusitis","volume":"11","author":"McFadden","year":"1997","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2006.07.024_bib140","first-page":"1","article-title":"Prognostic factors, outcomes and staging in ethmoid sinus\u00a0surgery","volume":"102","author":"Kennedy","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2006.07.024_bib141","first-page":"7","article-title":"Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samter's triad","volume":"29","author":"Amar","year":"2000","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.jaci.2006.07.024_bib142","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0091-6749(90)90222-P","article-title":"Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma","volume":"86","author":"Sweet","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0091-6749(82)90081-1","article-title":"Aspirin desensitization in aspirin sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period","volume":"69","author":"Pleskow","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1081-1206(10)61803-0","article-title":"Early effects of aspirin desensitization treatment in asthmatics with aspirin exacerbated respiratory disease","volume":"90","author":"Berges-Gimeno","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Treatment with aspirin desensitization in patients with aspirin exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib146","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-6749(96)70123-9","article-title":"Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies","volume":"98","author":"Stevenson","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.07.024_bib147","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/CRIAI:24:2:159","article-title":"Aspirin desensitization in patients with AERD","volume":"24","author":"Stevenson","year":"2003","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906015703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906015703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:03:38Z","timestamp":1758776618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674906015703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0091674906015703"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2006.07.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2006.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}